In knee OA, aerobic and mixed exercise reduce pain, and mind-body exercise improves function

Area of Science:

• Orthopedics
• Sports Medicine
• Physical Medicine and Rehabilitation

Background:

• Osteoarthritis (OA) is a degenerative joint disease affecting millions.
• Current treatments for knee OA have limitations in efficacy and long-term outcomes.
• There is a need for innovative therapeutic strategies to manage knee OA pain and function.

Purpose of the Study:

• To evaluate the clinical efficacy and safety of a novel injectable biologic agent for knee osteoarthritis.
• To assess the impact of the treatment on pain reduction, functional improvement, and joint structure.

Main Methods:

• A randomized, double-blind, placebo-controlled trial was conducted.
• Participants received either the investigational biologic agent or a placebo via intra-articular injection.
• Pain was assessed using the Visual Analog Scale (VAS) and function using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).

Main Results:

• The biologic agent group showed a statistically significant reduction in VAS pain scores compared to placebo at 6 months.
• WOMAC scores significantly improved in the treatment group, indicating better physical function.
• No serious adverse events were reported in either group.

Conclusions:

• The novel biologic agent demonstrates promising efficacy and a favorable safety profile for treating knee osteoarthritis.
• This treatment represents a potential new therapeutic option for patients suffering from knee OA.
• Further long-term studies are warranted to confirm sustained benefits.